LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | +64.3% | 391 | +105.8% | 0.00% | – |
| Q2 2023 | $14 | +7.7% | 190 | +3.8% | 0.00% | – |
| Q1 2023 | $13 | +8.3% | 183 | +4.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 176 | +10.7% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 159 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 159 | +59.0% | 0.00% | – |
| Q1 2022 | $11,000 | -47.6% | 100 | -24.8% | 0.00% | – |
| Q4 2021 | $21,000 | – | 133 | +6550.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 2 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |